Bioceltix Signs Advisory Agreement For FDA Regulatory Support

April 14 (Reuters) - Bioceltix S.A. BCXP.WA:

• SAID ON MONDAY THAT IT HAD SIGNED AN ADVISORY AGREEMENT FOR REGULATORY SUPPORT OF VETERINARY STEM CELL PRODUCTS IN US MARKET

• PARTNER TO ASSIST IN DIALOGUE WITH U.S. FOOD AND DRUG ADMINISTRATION (FDA) AND CENTER FOR VETERINARY MEDICINE (CVM)

• AGREEMENT SIGNED FOR PERIOD OF UP TO 3 YEARS

• ESTIMATES ABOUT 6 TO 9 MONTHS TO REACH FIRST MEETING WITH FDA/CVM

• POTENTIAL ADMINISTRATIVE FEE TOTALS $165,441 IF FEE WAIVER IS NOT GRANTED